Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.
Diaz, Fernando M
Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus. [electronic resource] - Virology Jan 2016 - 61-7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1096-0341
10.1016/j.virol.2015.10.033 doi
Animals
Antibodies, Viral--blood
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Female
Herpes Genitalis--immunology
Herpesvirus 2, Human--immunology
Herpesvirus Vaccines--administration & dosage
Mice, Inbred BALB C
Real-Time Polymerase Chain Reaction
Seroconversion
Treatment Outcome
Vaccines, Attenuated--administration & dosage
Viral Proteins--immunology
Virus Latency
Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus. [electronic resource] - Virology Jan 2016 - 61-7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1096-0341
10.1016/j.virol.2015.10.033 doi
Animals
Antibodies, Viral--blood
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Female
Herpes Genitalis--immunology
Herpesvirus 2, Human--immunology
Herpesvirus Vaccines--administration & dosage
Mice, Inbred BALB C
Real-Time Polymerase Chain Reaction
Seroconversion
Treatment Outcome
Vaccines, Attenuated--administration & dosage
Viral Proteins--immunology
Virus Latency